Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Circulate Health, Inc.

Circulate Health, Inc.

Stage unknownSeattle, WABiotechnology
Facts
Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. Dec 3, 2025
    Strategic Investment · amount undisclosed
    Khosla Ventures, LLC (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Circulate Health Announces Strategic Investment from Scrum Ventures”
  2. Jun 11, 2025
    Form D equity offering · $10.6M (form d sold) · 3 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Circulate Health, Inc. filed Form D: $10,600,001 sold of $11,999,999, Biotechnology”
Investors on record
1 edges
People
2 officers, 1 directors
Timeline
3
  1. Jan 9, 2026
    Circulate Health, Inc. filed Form D/A: $13,000,000 sold of $13,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Dec 3, 2025
    Circulate Health announced Strategic Investment
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
  3. Oct 22, 2025
    Circulate Health, Inc. filed Form D: $10,600,001 sold of $11,999,999, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
31 observations
Every observation on this company